Tandem Diabetes Care (TNDM) Restructuring Costs (2025)
Tandem Diabetes Care (TNDM) reported Restructuring Costs of $20.0 million for Q2 2025.
Tandem Diabetes Care (TNDM) Restructuring Costs (2025) Analysis & Trends
Tandem Diabetes Care has reported Restructuring Costs for 1 years, with the latest figure at $20.0 million in Q2 2025.
- For the quarter ending Q2 2025, Restructuring Costs changed N/A year-over-year to $20.0 million; the trailing twelve-month figure through Dec 2025 stood at $20.0 million (changed N/A YoY), and the FY2025 full-year result was $20.0 million, changed N/A from the prior year.
- Restructuring Costs for Q2 2025 stood at $20.0 million.
- The five-year high for Restructuring Costs was $20.0 million in Q2 2025, with the low at $20.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.04 Bn | 474.17 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 19.95 Mn |